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Abstract A rapid and highly sensitive receptor immuno-
assay for botulinum toxin (BT) has been developed using
ganglioside-incorporated liposomes. Botulism outbreaks are
relatively rare, but their results can be very severe, usually
leading to death from respiratory failure. To exert their tox-
icity, the biological toxins must first bind to receptors on
the cell surface, and the trisialoganglioside GT1b has been
identified as the cell receptor for BT. Therefore, in this
study, GT1b was used to prepare the ganglioside–lipo-
somes by spontaneous insertion into the phospholipid bi-
layer. In a sandwich-based, hybrid receptor immunoassay,
BT is detected as a colored band on a nitrocellulose mem-
brane strip, where BT bound to the GT1b-liposomes are
captured by anti-BT antibodies immobilized in a band
across the strip. The intensity of the colored band can be vi-
sually estimated, or measured by densitometry using com-
puter software. The limit of detection (LOD) for BT in the
lateral-flow assay system was 15 pg mL–1, which is compa-
rable to the limits of detection achieved with the most sen-
sitive assays previously reported. However, this rapid assay
can be completed in less than 20 min. These results demon-
strate that the sandwich assay using GT1b-liposomes for
detection of BT is rapid and very sensitive, suggesting the
possibility for detecting BT in field screening, simply and
reliably, without the need for complex instrumentation.
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Introduction
Biological toxins, viruses, and hormones must first bind
to cell surface receptors in order to act inside the cells. Af-
ter binding to the receptors, these biologically active mol-
ecules penetrate through the cell membrane, usually via
endocytosis, and then exert their activity inside the cell.
Carbohydrates, existing as glycolipids or glycoproteins on
the cell surface, have long been implicated as major re-
ceptors for biological toxins [1] and as receptors for hor-
mones and other small molecules. Gangliosides, sialic acid-
containing glycosphingolipids, are present in the plasma
membranes of most vertebrate cells. The various func-
tions of gangliosides have been studied, including their
use as receptors for biological toxins [2, 3]. Since van
Heyningen et al. reported that brain gangliosides bound
and deactivated cholera toxin [4], the toxin deactivation
effect of gangliosides has been studied with other toxins
such as botulinum toxin [5] and tetanus toxin [6], which
also suggested the function of gangliosides as toxin recep-
tors. Gangliosides contain both hydrophilic and hydropho-
bic regions and carry a negative charge. The hydrophobic
portion, ceramide, consists of a long-chain fatty acid
linked to the amino alcohol sphingosine through an amide
bond. The hydrophilic carbohydrate moiety is composed
of hexoses, N-acetylated hexosamines, and at least one
sialic acid molecule. In the membrane, the ceramide por-
tion is imbedded in the lipid bilayer, while the hydrophilic
oligosaccharide chain is exposed to the outer environment
[7]. This structure makes gangliosides well suited as a
surface receptor for toxins. The structure of trisialogan-
glioside GT1b is shown in Fig. 1. As toxin receptors, gan-
gliosides have been used in model membrane systems
where the gangliosides were incorporated into liposome
bilayers or lipid monolayers. Since gangliosides are nat-
ural cell membrane receptors, these ganglioside-incorpo-
rated liposomes can be a useful biomimetic model system
to study the interaction between biological toxins and
cell-surface gangliosides. Improved techniques to prepare
ganglioside–liposomes have also been applied to the de-
velopment of toxin detection assays that take advantage of
the strong and specific interactions between toxins and
gangliosides [8, 9, 10].
Liposomes, spherical vesicles composed of a phospho-
lipid bilayer surrounding an aqueous cavity, were originally
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developed to study cell membranes. However, because of
their ability to carry various water-soluble agents in their
aqueous cavity, liposomes have been used in clinical di-
agnostics, drug delivery, and even in the cosmetics and
food industries [11]. The use of liposomes in diagnostics
has several advantages over enzyme-linked assays. Lipo-
somes have the sites for ligands exposed on their surface
and relatively large volumes for containing dye or other
markers in their cavity, thus providing greatly enhanced
signals. Liposomes utilized in sandwich assay detection
systems mostly exist as immunoliposomes with antibod-
ies on their surface, or as nucleic acid-tagged liposomes.
Despite having specificity and strong affinity for biologi-
cal toxins comparable to those of antibodies, gangliosides
have not been widely used as receptors in liposome-based
assays until recently. Ganglioside-incorporated liposomes
have advantages over immunoliposomes because of the
amphiphilicity of the gangliosides. Gangliosides contain
the hydrophobic ceramide, which can be spontaneously
incorporated into a lipid bilayer structure, while antibod-
ies need several chemical steps for covalent conjugation
to the liposome structure.
Botulinum neurotoxin (BT) produced by Clostridium
botulinum is the most toxic substance known: as little as
0.05–0.1 µg is a lethal dose in humans. Patients with bot-
ulism show neurological symptoms of flaccid muscular
paralysis, with death resulting from respiratory failure if
left untreated. In addition, the high probability of bioter-
rorists using biological toxins as agents of mass destruc-
tion, makes these toxins of even more serious concern
[12]. Therefore, the development of rapid and sensitive
detection methods for BT is urgently needed. At present,
the mouse bioassay is the commonly accepted “gold-stan-
dard” method for the detection of BT [13]. Although it is
highly sensitive, with a detection limit of 10–20 pg mL–1,
the mouse bioassay is costly, time-consuming, and requires
the use of animals. To date, several detection methods have
been developed for BT as alternatives to the mouse bioas-
say: immunoassays, enzyme activity-based assays, and
polymerase chain reaction (PCR)-based assays [14, 15, 16,
17]. In this study, BT was detected using ganglioside–
liposomes containing the intensely red sulforhodamine B
(SRB) dye as the visual marker, and the trisialoganglio-
side GT1b receptor for BT was used for the preparation of
the liposomes. Anti-BT antibodies were immobilized in
narrow zones on plastic-backed nitrocellulose (NC) mem-
brane sheets, which were then cut into test strips. In this
sandwich assay system, BT was first bound to the GT1b
on the liposomes and these were then captured by the an-
tibodies in the analytical zone during capillary migration
through the test strip. The presence of BT was observed as
a colored band in the analytical zone on the strip. The in-
tensity of the dye color in the band was measured either
by visual estimation or by densitometry utilizing a com-
puter scanner. As described below, in addition to its speed
and specificity, the method has very high sensitivity, com-
parable to ELISA and the mouse bioassay, thereby pro-
viding a promising alternative detection approach.
Materials and methods
Materials
Dipalmitoyl phosphatidylcholine (DPPC), dipalmitoyl phosphati-
dylethanolamine (DPPE), and dipalmitoyl phosphatidylglycerol
(DPPG) were purchased from Avanti Polar Lipids, Inc. (Alabaster,
AL). N-(κ-maleimidoundecanoyloxy)sulfosuccinimide ester (sulfo-
KMUS), N-succinimidyl-S-acetylthiopropionate (SATA), hydrox-
ylamine hydrochloride, and N-ethylmaleimide were purchased from
Pierce (Rockford, IL). Trisialoganglioside (GT1b), sulforhodamine
B (SRB), cholesterol, N-acetylneuraminic acid (NANA), and all
other chemicals were purchased from Sigma Chemical Co. (St.
Louis, MO). To avoid biological hazards, commercialized toxin
subunits or toxoids (formaldehyde-inactivated toxins) were used, if
available, in this study. Botulinum neurotoxin type A heavy chain,
tetanus toxoid, diphtheria toxoid, and Escherichia coli heat-stable
toxin (STa) were obtained from List Biological Laboratories, Inc.
(Campbell, CA). Cholera toxin B subunit was purchased from
Sigma Chemical Co. Affinity-purified rabbit polyclonal antibodies
to botulinum toxin subtype A were purchased from Biogenesis
(Poole, England). Nitrocellulose (NC) membranes with plastic back-
ing (10-µm pore size) were obtained from Millipore (Bedford, MA).
Polycarbonate (PC) filter membranes of 0.2-µm pore size came
from Whatman International Ltd. (Maidstone, England). The STa
used in this study is an intact toxin, so it requires handling precau-
tions. Appropriate laboratory attire should be worn, including a lab
coat, gloves, and safety glasses. In case of exposure, the area of the
Fig. 1 Structure of the trisialoganglioside GT1b, which is one of
the natural receptors for botulinum neurotoxin. Abbreviations:
Glc, glucose; Gal, galactose; GalNAc, N-acetylgalactosamine;
NANA, N-acetylneuraminic acid (sialic acid)
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body that comes into contact with STa should be washed thor-
oughly. STa can be inactivated by 0.04 mM dithiothreitol or 0.1 M
β-mercaptoethanol. STa-contaminated materials can be inactivated
by autoclaving at 121°C and 15 psi.
Preparation of GT1b-liposomes
GT1b-liposomes were prepared by the extrusion method, after
repetitive freeze–thaw cycles [18], from a mixture of DPPC,
DPPG, cholesterol, and GT1b in a molar ratio of 40.3:4.2:40.9:1.3.
An 86.7-µmol aliquot of the lipid mixture was completely dis-
solved in a 100-mL round-bottom flask by swirling in 7 mL of a
chloroform/methanol mixture (6:1, v/v). The dissolved lipid mix-
ture was dried by evaporation under vacuum on a rotary evaporator
to form a thin lipid film on the flask wall. Four mL of a 150 mM
aqueous SRB solution, in 20 mM HEPES buffer (pH 7.5) contain-
ing 0.01% sodium azide, were added to the dry lipid mixture. Af-
ter gentle swirling, 5 cycles of freezing and thawing were per-
formed, by alternating placement of the flask in a dry ice/acetone
bath and a 50°C water bath. The hydrated liposomes were extruded
through a 0.2-µm pore size PC filter membrane using a mini-ex-
truder (Avanti Polar Lipids, Inc.). The resulting liposomes were
gel-filtered through a 1.5×25 cm Sephadex G-50 column to re-
move unencapsulated dye.
The phospholipid concentration in the resulting liposomes was
determined by quantitation of phosphorus using Bartlett’s phospho-
rus assay [19]. The mean diameter of the liposomes was measured
by laser-diffraction particle-size analysis with an LS particle-size
analyzer (Coulter Scientific Instruments, Hialeah, FL). The ganglio-
side concentration in the liposomes was quantified by the method
of Hikita et al. [20] using NANA as the standard. Liposome con-
centration, receptor concentration and the number of SRB mole-
cules per liposome were determined as described previously [21].
Preparation of immunoliposomes
Preparation of DPPE-ATA
For conjugation of antibodies to liposomes, DPPE-ATA was 
prepared from DPPE and a thiolating reagent, SATA (21). DPPE
(7.2 µmol) was dissolved in 1 mL of 0.7% (v/v) triethylamine in
chloroform. SATA (14.3 µmol) was added to the DPPE solution
and sonicated for 1 min under nitrogen gas. The flask containing
the mixture was capped and stirred for 20 min at room tempera-
ture. Addition of 3 mL of chloroform followed by evaporation was
repeated until all traces of triethylamine were completely removed.
The final product was dissolved in 1 mL of chloroform.
Preparation of liposomes
Liposomes were prepared by the extrusion method described above.
For the immunoliposomes, DPPE-ATA (3.6 µmol) was used in place
of GT1b. Hydroxylamine solution (0.5 M hydroxylamine, 25 mM
EDTA in 0.1 M HEPES buffer, pH 7.5) was added to the final li-
posome solution (1:10, v/v) and the mixture was incubated in the
dark for 2 h at room temperature.
Modification of antibodies for conjugation
Polyclonal antibodies to botulinum subtype A were dialyzed over-
night against PBS (pH 7.4), containing 1 mM ethylenediaminete-
traacetic acid (EDTA) and 0.01% sodium azide. Sulfo-KMUS was
added to the dialyzed antibodies at a molar ratio of 15:1 (sulfo-
KMUS:antibody), and the mixture was incubated with shaking for
3 h at room temperature in the dark. The reaction was stopped by
adding 0.5 M Tris (pH 7.8) at 20 times the molar ratio of the sulfo-
KMUS used. The reaction mixture was incubated for an additional
15 min at room temperature and then dialyzed in a DispoDialyzer
(molecular weight cut-off 15,000, Spectrum Lab. Inc., Rancho
Dominguez, CA) against Tris-buffered saline (TBS, pH 7.4) con-
taining 0.01% sodium azide.
Conjugation of maleimide-derivatized antibodies to liposomes
Conjugation was achieved by incubating derivatized antibodies
with thiolated liposomes for 3.5 h at room temperature and then
overnight at 4°C. The reaction was carried out in the dark under ni-
trogen gas. After the incubation, the immunoliposomes were
treated with 100 mM N-ethylmaleimide in PBS (pH 7.4) for 30 min
at room temperature to quench the remaining thiol groups and then
filtered through a 1.5×17 cm Sepharose CL-4B column, equili-
brated with TBS containing 0.01% sodium azide, to remove un-
conjugated antibodies.
Fig. 2 The test strip assay for-
mat. The BT in the reaction
mixture binds to the ganglio-
sides on the liposome surface.
The BT–GT1b-liposome com-
plex migrates through the ni-
trocellulose test strip by capil-
lary action until it reaches the
analytical zone, where toxins
in the complexes are captured
by immobilized antibodies.
This binding is shown as a
dark band on the test strip
Preparation of test strips
Test strips were prepared as reported previously [21], with modifi-
cations. Plastic-backed NC membrane sheet was cut to the desired
size (20×5 cm or 20×8 cm), pre-wetted with 10% (v/v) methanol in
phosphate-buffered saline (PBS, pH 7.4) containing 0.01% sodium
azide, and dried under vacuum at room temperature. Antibodies to
botulinum neurotoxin subtype A (concentration of 1 mg mL–1) in
PBS were applied to the analytical zone (approximately 2 cm from
one end of the membrane) of the NC membranes using a Linomat
IV TLC Sampler (Camag Scientific, Wrightsville Beach, NC). The
antibody-immobilized membranes were dried for 1.5 h at room
temperature, then incubated in the blocking solution containing
2% polyvinylpyrrolidone (PVP), 0.01% gelatin, 0.002% Tween 20
in PBS, for 1 h with constant shaking, and dried overnight under
vacuum at room temperature. After drying, the membranes were
cut into test strips (5×50 mm or 5×80 mm) and a filter paper pad
was attached to the top of the test strip to provide additional ab-
sorbency for the migration process.
Assay formats
The assay was performed by adding 60 µL of GT1b-liposome stock
solution, diluted with TBS, to 40 µL of the sample in glass test
tubes (10×75 mm). The total volume of the reaction mixture was
100 µL. After the contents were mixed briefly by swirling, the test
strip was inserted into the mixture and left in the tube until all of
the mixture solution was drawn from the bottom of the test tube.
This capillary migration process took approximately 15–20 min.
The assay format is depicted in Fig. 2.
Detection and quantitation
The signal color on the test strips can be detected visually. For
quantitation of the signal intensity, grayscale densitometry can be
used. The test strips were scanned using an Expresstion 636 color
image scanner (Epson, Torrance, CA), and the scanned images were
converted into grayscale readings. The intensity of each signal was
quantified with Scan Analysis densitometry software (Biosoft,
Ferguson, MO)
Results and discussion
Preparation and characterization of GT1b-liposomes
Following repetitive freeze–thaw cycles, the GT1b-incor-
porated liposomes, encapsulating SRB, were prepared by
the extrusion method. To decide the optimal amount of GT1b,
several batches of liposomes were prepared with different
amounts of GT1b in the lipid mixture, and the binding of
BT to those liposomes was compared. The highest binding
was observed when GT1b was approximately 1–2 mol%
of the total lipids in the lipid mixture (data not shown).
Higher concentrations of GT1b made the liposomes un-
stable because of the large carbohydrate moiety. There-
fore, to achieve the highest stability, the concentration of
GT1b was maintained at less than 2 mol% of total lipids in
the lipid mixture. The DMB assay showed that about 40%
of the GT1b in the lipid mixture was incorporated into the
resulting liposomes.
The characteristics of the liposomes used in these stud-
ies are shown in Table 1. The mean diameter of GT1b-li-
posomes was measured by a particle-size analyzer to be
197 nm. This result seems reasonable because the lipo-
somes were extruded through 0.2-µm pore size PC mem-
brane filter and, without any sonication during prepara-
tion, the size of liposomes are only affected by the pore
size of the membrane filter used during the extrusion [22].
With the assumption that the thickness of the bilayer is 
4 nm [23], the internal volume of a single liposome can be
calculated from the diameter. From the diameter of a lipo-
some, the lipid concentration, and the concentration of en-
capsulated SRB, all other characteristics could be calcu-
lated as described previously [21]. The mean diameter,
volume, and SRB content of a single GT1b-liposome
molecule were comparable to those of liposomes prepared
for previous studies of liposomal test strip assay [24]. The
number of ganglioside molecules on the liposome surface,
2.1×104, was similar to the number of 1.9×104, reported
by Singh et al. [9]. The stability of the liposomes was de-
termined by measuring the fluorescence of SRB that leaked
out of the liposomes during storage, and no significant
changes in liposome stability were observed over 9 months
of storage at 4°C in the dark. All buffers used in the lipo-
some preparation and the assay were adjusted to have the
same osmolarity as the encapsulated SRB, in order to pre-
vent osmotic pressure-related swelling or crenation.
Development of the test strip assay for BT detection
The test strip assay format used in this study is depicted in
Fig. 2. The assay is based on the strong binding between
the sample BT and GT1b on the liposome surface, capil-
lary migration on a nitrocellulose strip, and detection of
the captured BT–liposome complex in an analytical zone.
To minimize the nonspecific binding of GT1b-liposomes
to the test strip, the NC membrane was treated with a
blocking solution containing PVP. Of the blocking agents
tested, PVP, bovine serum albumin (BSA), and gelatin
showed consistently low backgrounds (data not shown).
However, in the test strips blocked with BSA and gelatin,
the reaction mixture appeared to migrate more slowly. Since
the objective of this study was to develop a rapid detec-
tion method, PVP was chosen as the blocking reagent,
with only a small amount (0.01%) of gelatin added.
Tween-20 was also added to the blocking solution for uni-
form migration of liposomes, but its concentration was
only 0.002% to avoid the lysis of the liposomes.
In the assay, BT in the sample binds strongly and
specifically to GT1b on the liposomes to form BT–GT1b-
liposome complexes that can migrate through the NC test
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Table 1 Characteristics of GT1b-liposomes
Parameter Value
Mean diameter (nm) 197±33
Volume (µL) 4.0×10–12
Liposome concentration (liposomes mL–1) 5.3×1011
SRB concentration (mM) 150
Number of SRB per liposome (molecules liposome–1) 3.2×105
Number of GT1b per liposome (molecules liposome–1) 2.1×104
strip by capillary action. These complexes are then cap-
tured by immobilized anti-BT antibodies in the analytical
zone of the strips and can be observed as a colored band
in this zone due to the SRB encapsulated inside the trans-
parent liposomes. The appearance of the actual test strips
showing the colored bands due to different concentrations
of BT is illustrated in Fig. 3. With various concentrations
of BT (0–10 µg mL–1) in buffer, the intensity of the SRB
signal in the analytical zone can be visually detected. The
intensity of the band is proportional to the amount of toxin
in the sample, and the visual detection limit for BT is ap-
proximately 100 pg mL–1.
The analytical sensitivity and detection limit of the test
strip assay for BT detection was determined from a dose–
response curve (Fig. 4). Dose–response data were ob-
tained by scanning densitometry of the test strips, which
were run in various concentrations of BT. The limit of de-
tection (LOD) is defined as the lowest concentration of
toxin producing a signal intensity 3 times higher than the
standard deviation of the intensity of the sample without
toxin (i.e., the negative control). By this definition, the in-
strumental (densitometry) LOD of the current assay for
BT is estimated to be 15 pg mL–1, which is about 3 mLD50
(mouse 50% lethal dose). The visual detection limit is
about a factor of 10 higher. In the dose–response curve for
BT, the intensity of the binding signal increases with in-
creasing concentration of BT in the sample, providing a
dynamic analytical range between approximately 101 and
106 pg mL–1, or about 5 orders of magnitude. Several re-
search groups reported that their detection assays for bio-
logical toxins, including BT, utilizing ganglioside–lipo-
somes showed high sensitivity [8, 9, 25]. However, these
assays detected the color change due to conformational
change in the liposomes [8] or the signal from dye-mark-
ers or enzymes on the liposome surface [9, 25]. In this
study, we used dye-encapsulating liposomes, which, be-
cause of the much larger number of dye molecules con-
tained in each liposome, produced a much higher signal
intensity, thereby resulting in higher sensitivity. The LOD
of 3 mLD50 is comparable to the most sensitive BT detec-
tion assays previously reported [15, 16, 26, 27] for which
the detection limits reach the level of the mouse bioassay.
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Fig. 3 Scanned images of representative nitrocellulose test strips.
Strips were run at room temperature, as described in “Materials
and methods”. Each strip was inserted into the test tube containing
100 µL of the reaction mixture of GT1b-liposomes and BT at the
indicated concentrations: A negative control, B 1×10–5 µg mL–1,
C 1×10–4 µg mL–1, D 1×10–3 µg mL–1, E 1×10–2 µg mL–1, F 1×
10–1 µg mL–1, G 1 µg mL–1, H 10 µg mL–1
Fig. 4 Dose–response curve for botulinum neurotoxin, generated
from test strip assays using GT1b-liposomes. The solid line repre-
sents the third-order polynomial curve fit, with an R2 value of
0.996. The straight horizontal line indicates the limit of detection,
defined as the color intensity 3 times higher than the standard de-
viation of the background (negative control) signal. Each point
represents four replicates of grayscale values in the analytical zone
Table 2 Sensitivity of various detection assays for botulinum neu-
rotoxina
Method LOD of Assay Refer-
toxin type A time ence
(mLD50)b
Mouse bioassay 1–2 3–4 days [32]
RPHA 1.3–1.6 5–6 h [33]
ELISA 1–5 h
2 [34]
9 [35]
1–2 [15]
ELCA <1 >18 hc [27]
Enzymatic assayd 0.5 5–6 h [16]
This study 3 20 min
aAbbreviations: mLD50, mouse 50% lethal dose; RPHA, reversed
passive hemagglutination; ELISA, enzyme-linked immunosorbent
assay, ELCA, enzyme-linked coagulation assay
b1 mLD50 for chromatographically purified type A botulinum neu-
rotoxin has been calculated as approximately 6 pg mL–1 [32]. At 
1 mLD50, 50% of mice injected with 1 mL will die
cIncluding the immunobinding phase
dPerformed with botulinum neurotoxin type B
These previously reported assays, based on ELISA or the
enzymatic activity of BT, are time-consuming and need to be
performed by well-trained personnel. In contrast, the as-
say developed in this study can be completed within 20 min
and is very easy to perform. Therefore, this result suggests
a BT detection assay using GT1b-liposomes can replace
existing methods. In Table 2, the GT1b-liposome assay is
compared to other previously reported BT detection as-
says.
Comparison of the sensitivity of GT1b-liposomes 
to immunoliposomes for BT detection
The sensitivity of the BT detection assay using GT1b-li-
posomes was compared to immunoliposomes with anti-
bodies to BT on the liposome surface (Fig. 5). The LOD
for BT in the immunoliposome assay system was esti-
mated from the dose–response curve to be 40 pg mL–1. At
concentrations equal to or higher than 100 pg mL–1, the
signal could be visually detected. This result suggests that
the binding of the ganglioside to the toxin is as strong and
specific as the binding of antibodies to the toxin. The sen-
sitivity of the immunoliposome assay system is slightly
lower, the detection limit a little higher (LOD=40 pg mL–1
versus 15 pg mL–1), and the signal intensity decreased
more at higher concentrations of toxin as compared to the
GT1b-liposome assay system. This poorer performance of
the immunoliposome assay can possibly be explained by
the format used in this study. In the sandwich assay for-
mat of the immunoliposome assay, the same antibodies
were used for coating the analytical zone on test strips and
for conjugation onto the liposome surface. This would re-
sult in these antibodies competing for the same epitopes
on the toxin, which could ultimately lead to the lower sen-
sitivity of the assay. This problem could possibly be miti-
gated by using antibodies to two different BT epitopes,
one for use on the test strip analytical zone and the other
for conjugation to liposomes. However, considering the
complex and time-consuming (at least 2 days) process re-
quired to prepare immunoliposomes, ganglioside–lipo-
somes have a distinct advantage over immunoliposomes
in their ease of preparation.
Specificity of a capillary migration test strip assay 
for BT detection
To evaluate the specificity of the test strip assay for BT,
the assay was performed substituting various other gan-
glioside-binding toxins for BT. For this purpose, cholera
toxin (CT) from Vibrio cholerae, diphtheria toxin (DT)
from Corynebacterium diphtheriae, E. coli heat-stable toxin
(STa), and tetanus toxin (TT) from Clostridium tetani
were used. For safety purposes, commercially available
toxoids or subunits of toxin were used in this study, ex-
cept for STa. Each toxin was added to the assay system at
high concentration (10 µg mL–1), and the signal intensity
was measured, as described in “Materials and methods”.
As shown in Fig. 6, the BT detection assay using GT1b-li-
posomes showed a high signal intensity for BT over the
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Fig. 5 Comparison of the dose–response curves for immunolipo-
somes (E) with GT1b-liposomes (K) for botulinum neurotoxin de-
tection. The solid line represents the curve fit for immunolipo-
somes, and the dashed line represents the curve fit for GT1b-lipo-
somes (as shown in Fig. 4), with R2 values of 0.997 and 0.996, re-
spectively. The straight horizontal line indicates the limit of detec-
tion for the immunoliposomes, defined as the color intensity 3 times
higher than the standard deviation of the background (negative
control) signal. Each point represents four replicates of grayscale
values in the analytical zone
Fig. 6 Specificity of the BT detection assay using GT1b-lipo-
somes. A 10 µg mL–1 aliquot of each toxin was dissolved in TBS
and used in the assay. The data shown are an average of 3 repli-
cates. Abbreviations: BT, botulinum toxin; CT, cholera toxin; DT,
diphtheria toxin; STa, E. coli heat-stable toxin; TT, tetanus toxin
other toxins, which suggests specificity of the assay for
BT detection. In this experiment, TT showed a little
higher binding signal than the other toxins and this could
be the result of the similarity of TT and BT in terms of
structure and amino acid sequence [28, 29]. In addition, it
has been reported that tetanus toxin binds to gangliosides,
specifically to the disialoganglioside GD1b and GT1b, as
membrane receptors [30, 31]. Despite the fact that TT in
the sample can also bind to GT1b on the liposomes, the
result from this study suggests that the antibodies to BT,
immobilized on the test strip, can provide enough speci-
ficity to distinguish BT from TT. The high specificity of
the detection assay, which requires binding to two sepa-
rate and distinct receptors, provides an advantage over
other immunological detection methods, which show the
problems of false-positive signals from cross-reactivity,
especially in sandwich-type assays.
Conclusions
In this study, GT1b-liposomes were used in a sandwich
test strip assay for botulinum neurotoxin detection. We
demonstrated that GT1b-liposomes can interact with BT
at least as strongly as immunoliposomes. The assay de-
veloped in this study provides detection levels compara-
ble to the mouse bioassay and most of the other previ-
ously reported assays, but has the added advantages of
simplicity and rapidity. These results show that a capillary
migration test strip assay can be an alternative assay sys-
tem for BT detection, which can also be applied to the
field screening of food or environmental samples. This as-
say system could be applied to the detection of other bio-
logical toxins that use gangliosides as their cell receptors.
However, for the application of this assay to field screen-
ing, the effect of food matrices will be evaluated. Prelim-
inary studies on a variety of vegetable and seafood sam-
ples have demonstrated only a moderate loss in sensitivity
with the exception of certain fish, such as salmon, that are
very high in fatty acids that appear to interfere with lipo-
some integrity. Also, the effect of other organisms present
in the sample on the sensitivity of this assay will be stud-
ied.
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